Specialist website design for Cambridge's life sciences, biotech and pharmaceutical companies. Technically credible, scientifically literate sites that communicate complex research clearly to investors, partners and talent.
Tell us where to send it. We reply within one working day.
Cambridge is the heart of UK life sciences — from the Biomedical Campus to the science parks ringing the city, it is home to biotech, pharmaceutical and clinical-research companies operating at the frontier. Their audiences are exacting: investors, pharma partners, regulators and highly qualified candidates who will judge a company on whether its website communicates complex science with precision and credibility.
Aethus designs websites for Cambridge life sciences, biotech and pharmaceutical organisations that meet that bar. We translate complex research, pipelines and platforms into clear, credible digital narratives — built on modern technology, scientifically literate, and tuned to be found by the partners and talent a Cambridge science company needs to reach.
The hardest job for a life sciences website is communication: explaining a mechanism of action, a platform technology or a clinical pipeline to audiences who range from specialist investors to non-expert stakeholders, without diluting the science or drowning it in jargon. We structure that content deliberately — layered so a partner can go deep while a generalist grasps the value quickly — and present it with the visual precision a Cambridge deep-tech company expects.
Done well, this becomes a genuine asset in fundraising, partnering and recruitment, not just a brochure.
A Cambridge life sciences company is usually selling three things at once: an investment case, a partnering opportunity, and a place to work. We design distinct, credible journeys for each — a clear value narrative and pipeline for investors and pharma partners, and an authentic careers presence to attract the scientific talent that is the real constraint on growth.
We build structured, maintainable ways to present your pipeline, peer-reviewed publications and clinical-trial information — the evidence base that establishes credibility with sophisticated audiences.
A deep-tech company cannot afford a website that feels behind the times. We build on a modern, fast, performance-first stack, with accessibility and GDPR compliance built in, and an architecture that scales as you progress through funding rounds and pipeline milestones.
Results
Our clearest results so far come from private eye-care practices. The lines show direction and shape; the figures stay private.
Vision-correction clinic, London & Surrey
Before and after the rebuild. The line turns where the new website went live.
Use the left and right arrow keys to step through the months. Figures are deliberately not shown.
Source: Google Search Console, monthly, between Sept 2025 and Sept 2026. Shown as trends, not figures, to protect our clients’ privacy.
Yes. We are experienced at translating complex science — mechanisms, platforms, pipelines and trial data — into clear, credible content for mixed audiences of investors, partners, regulators and candidates, without oversimplifying or overclaiming.
We build structured, easily maintainable sections for pipelines, peer-reviewed publications and clinical-trial information, so your evidence base is clear and current as it evolves.
Yes — we work with biotech, pharma and clinical-research companies across the Cambridge cluster, and tailor local and sector signals to your audience and location.
We build on a scalable, modern architecture designed to grow with funding rounds, new pipeline assets and expanding teams, without needing a rebuild every couple of years.
Pick a time — it takes under a minute.
Loading available times…
Compliance Scorecard. 12 questions on CQC display, UK GDPR/PECR, accessibility and advertising rules. Instant score and a plain-English action plan. Take the compliance scorecard →
Trusted by growing UK businesses and clinics
Ask us anything
Hi! How can we help you today?
Conversations may be reviewed to improve our service. Privacy policy.
